Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 125
of 7Next
1:

Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.

Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Lewis JL, Stower MJ, Maitland NJ, Collins AT.

Genome Biol. 2008;9(5):R83. Epub 2008 May 20.

PMID: 18492237 [PubMed - indexed for MEDLINE]

2:

Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.

Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS.

Cancer Res. 2007 Apr 1;67(7):3153-61.

PMID: 17409422 [PubMed - indexed for MEDLINE]

3:

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.

Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL.

Br J Cancer. 2008 Feb 26;98(4):756-65. Epub 2008 Feb 12.

PMID: 18268494 [PubMed - indexed for MEDLINE]

4:

Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56.

PMID: 16740744 [PubMed - indexed for MEDLINE]

6:

Prostate cancer stem cells: a new target for therapy.

Maitland NJ, Collins AT.

J Clin Oncol. 2008 Jun 10;26(17):2862-70. Review.

PMID: 18539965 [PubMed - indexed for MEDLINE]

7:

Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.

Grzmil M, Thelen P, Hemmerlein B, Schweyer S, Voigt S, Mury D, Burfeind P.

Am J Pathol. 2003 Aug;163(2):543-52.

PMID: 12875974 [PubMed - indexed for MEDLINE]

8:

The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.

Heer R, Robson CN, Shenton BK, Leung HY.

J Cell Physiol. 2007 Sep;212(3):572-8. Erratum in: J Cell Physiol. 2008 Apr;215(1):283-4.

PMID: 17541959 [PubMed - indexed for MEDLINE]

9:

Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.

Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C.

Histol Histopathol. 2000 Apr;15(2):365-74.

PMID: 10809354 [PubMed - indexed for MEDLINE]

11:

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.

PMID: 16963837 [PubMed - indexed for MEDLINE]

12:

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Suh J, Rabson AB.

J Cell Biochem. 2004 Jan 1;91(1):100-17. Review.

PMID: 14689584 [PubMed - indexed for MEDLINE]

13:

Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM.

Carcinogenesis. 2006 Oct;27(10):1980-90. Epub 2006 Apr 10.

PMID: 16606632 [PubMed - indexed for MEDLINE]

14:

Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.

Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB.

Prostate. 2001 Sep 15;48(4):305-15.

PMID: 11536311 [PubMed - indexed for MEDLINE]

15:

Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK.

Cancer Lett. 2008 Jan 18;259(1):28-38. Epub 2007 Oct 30.

PMID: 17977648 [PubMed - indexed for MEDLINE]

16:

Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.

Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P.

Mol Cancer. 2008 Jan 21;7:7.

PMID: 18208603 [PubMed - indexed for MEDLINE]

17:

DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.

Reyes I, Tiwari R, Geliebter J, Reyes N.

Biomedica. 2007 Jun;27(2):190-203. Epub 2007 Aug 21.

PMID: 17713630 [PubMed - indexed for MEDLINE]

18:

Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.

Zerbini LF, Wang Y, Cho JY, Libermann TA.

Cancer Res. 2003 May 1;63(9):2206-15.

PMID: 12727841 [PubMed - indexed for MEDLINE]

19:

Downregulation of several fibulin genes in prostate cancer.

Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, Müller M, Schulz WA.

Prostate. 2007 Dec 1;67(16):1770-80.

PMID: 17929269 [PubMed - indexed for MEDLINE]

20:

Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.

Zhao H, Ramos CF, Brooks JD, Peehl DM.

J Cell Physiol. 2007 Jan;210(1):111-21.

PMID: 17044071 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 125
of 7Next